Aromatase inhibition plus/minus Src inhibitor saracatinib (AZD0530) in advanced breast cancer therapy (ARISTACAT): a randomised phase II study
Titel:
Aromatase inhibition plus/minus Src inhibitor saracatinib (AZD0530) in advanced breast cancer therapy (ARISTACAT): a randomised phase II study
Auteur:
Oswald, Ailsa J. Symeonides, Stefan N. Wheatley, Duncan Chan, Stephen Brunt, Adrian Murray McAdam, Karen Schmid, Peter Waters, Simon Poole, Christopher Twelves, Chris Perren, Timothy Bartlett, John Piper, Tammy Chisholm, Eve Macdonald Welsh, Michelle Hill, Robert Hopcroft, Lisa E. M. Barrett-Lee, Peter Cameron, David A.